A detailed history of Heartwood Wealth Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Heartwood Wealth Advisors LLC holds 1,203 shares of ABBV stock, worth $244,870. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,203
Previous 1,203 -0.0%
Holding current value
$244,870
Previous $206,000 15.05%
% of portfolio
0.03%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 02, 2024

SELL
$159.82 - $182.1 $18,858 - $21,487
-118 Reduced 8.93%
1,203 $219,000
Q4 2023

Jan 17, 2024

BUY
$137.6 - $154.97 $181,769 - $204,715
1,321 New
1,321 $204,000
Q1 2023

Apr 14, 2023

BUY
$144.61 - $166.54 $217,927 - $250,975
1,507 New
1,507 $240,000
Q2 2022

Jul 25, 2022

SELL
$137.62 - $174.96 $190,466 - $242,144
-1,384 Closed
0 $0
Q1 2022

Apr 26, 2022

BUY
$131.98 - $163.75 $182,660 - $226,630
1,384 New
1,384 $224,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Heartwood Wealth Advisors LLC Portfolio

Follow Heartwood Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartwood Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Heartwood Wealth Advisors LLC with notifications on news.